Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on Shield Therapeutics Plc. We currently have 361 research reports from 9 professional analysts.
- Open: 6.50p
- Range Today: 6.40/6.59p
- 52 Week: 5.36/36.9p
- Daily Volume: 344.6k
- Daily Liquidity: 0.06%
- # Shares: 585.7m
- Market Cap: £38.1m
- Latest PE (hist):
- Div Yield:
Date | Source | Announcement |
---|---|---|
23Jan23 11:15 | DGAP-News | Hardman & Co Q&A on Shield Therapeutics (STX): Positioned for profitability with Viatris deal and its additional capital |
13Jan23 10:30 | RNS | Shield Therapeutics - Holding(s) in Company |
13Jan23 07:15 | DGAP-News | Hardman & Co Research: Shield Therapeutics (STX) - Positioned for growth and profitability |
12Jan23 14:40 | RNS | Shield Therapeutics - Holding(s) in Company |
12Jan23 14:15 | RNS | Shield Therapeutics - Holding(s) in Company |
09Jan23 17:10 | RNS | Shield Therapeutics - Partial AOP Loan Conversion |
09Jan23 15:56 | RNS | Shield Therapeutics - Holding(s) in Company |
Share: